“The reality is, when you’re optimizing for production, you start looking at a price/performance,” Guillermo Rauch tells TechCrunch.
Related Posts
Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic…
Melania Trump wants a robot to homeschool your child
The first lady sees AI and robotics playing a prominent role in the future of American education.
IBM: How robust AI governance protects enterprise margins
To protect enterprise margins, business leaders must invest in robust AI governance to securely manage AI infrastructure. When…